Results 221 to 230 of about 417,438 (262)

Mitigating Teclistamab Toxicity: Prophylactic Tocilizumab and Timing of Immunoglobulin Replacement Therapy in a Nationwide Cohort

open access: yes
American Journal of Hematology, EarlyView.
Astrid Hundebøll Torpe   +14 more
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Interleukin-38 in atherosclerosis

Clinica Chimica Acta, 2022
Chronic inflammation caused by immune cells and their mediators is a characteristic of atherosclerosis. Interleukin-38 (IL-38), a member of the IL-1 family, exerts multiple anti-inflammatory effects via specific ligand-receptor interactions. Upon recognizing a specific receptor, IL-38 restrains mitogen-activated protein kinase (MAPK), nuclear factor ...
Xiao-Hong Zhang   +3 more
openaire   +2 more sources

Assessment of the levels of interleukin-17 and interleukin-38 in thyroid-associated ophthalmopathy patients

International Ophthalmology, 2023
The objective of the study was to analyse the levels of IL-17 and IL-38 in the samples of unstimulated tears, orbital adipose tissues, and sera of patients diagnosed with active forms of TAO. The correlation of the levels of IL-17 and IL-38 with clinical activity score (CAS) was scrutinized.A study was conducted at the Kazakhstan Scientific Research ...
Ainura, Mussakulova   +8 more
openaire   +2 more sources

Biology of interleukin-38 and its role in chronic inflammatory diseases

International Immunopharmacology, 2021
Interleukin (IL)-38 is the tenth member of the IL-1 cytokine family. IL-38 shares high similarity with IL-36Ra and IL-1Ra and can bind to their receptors, thus exerting an anti-inflammatory effect. Despite the lack of a signal peptide, IL-38 can be released from several cell types, but its maturation process remains obscure.
Hua-song Xia   +4 more
openaire   +2 more sources

Plasma interleukin-38 in patients with rheumatoid arthritis

International Immunopharmacology, 2018
Previous studies have indicated that interleukin-38 (IL-38) is involved in rheumatoid arthritis (RA). The present study aims to assess plasma levels of IL-38 in RA and discuss the potential of IL-38 as a biomarker for RA. Protein concentrations of IL-38 were examined by enzyme-linked immunosorbent assay, and the mRNA level of IL-38 was tested by ...
Wang-Dong, Xu   +3 more
openaire   +2 more sources

Interleukin-38 and Insulin Resistance

Endocrine, Metabolic & Immune Disorders - Drug Targets
Abstract: Insulin resistance, i.e., decreased biological response to insulin, is a risk factor for many diseases, such as obesity, type 2 diabetes (T2DM), cardiovascular disease, polycystic ovary syndrome, some forms of cancer and neurodegenerative diseases.
Kamil Klejbuk, Marek Strączkowski
openaire   +2 more sources

The Effect of Interleukin 38 on Inflammation-induced Corneal Neovascularization

Current Molecular Medicine, 2019
Background: Angiogenesis is tightly linked to inflammation. Cytokines of interleukin 1 (IL-1) family are key mediators in modulating inflammatory responses. Methods: In this study, we examined the role of IL-38, a member of the IL-1 family, in mediating inflammation-induced angiogenesis.
Jiangli, Zhu   +8 more
openaire   +2 more sources

Investigation of Interleukin-38 in patients with primary Sjögren’s Syndrome

Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi, 2022
Aim: Interleukin-38 has been involved as an inflammatory mediator in rheumatic diseases. However, little is known about the role of IL-38 in the development of primary Sjögren’s syndrome. The present study aimed to evaluate the role of IL-38 in primary Sjögren’s syndrome and its clinical relevance.
Selcan GÜLTUNA   +2 more
openaire   +1 more source

Serum interleukin-38 and -41 levels as candidate biomarkers in male infertility

Immunology Letters, 2023
Interleukin (IL)-38 and IL-41 are novel cytokines, but their role in male infertility (MI) is unknown. The purpose of this study was to measure the levels of serum IL-38 and IL-41 in patients with MI and correlate these levels with semen indexes.Eighty-two patients with MI and 45 healthy controls (HC) were recruited for this study.
Chunhao, Rong   +4 more
openaire   +2 more sources

Interleukin-38 overexpression prevents bleomycin-induced mouse pulmonary fibrosis

Naunyn-Schmiedeberg's Archives of Pharmacology, 2020
Pulmonary fibrosis is a kind of pulmonary disorder with chronic inflammation and excessive collagen deposition, and its etiology is not clear. Interleukin (IL)-38 is a new member of IL-1 family cytokines, but its role in pulmonary fibrosis has not been elucidated.
Zhiwei Xu   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy